Prospective Randomized Controlled Trial Comparing Adjuvant Chemotherapy vs. No Chemotherapy for Patients with Carcinoma of Gallbladder Undergoing Curative Resection
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 26 (2) , 398-407
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysisBMC Cancer, 2015
- SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaJournal of Clinical Oncology, 2015
- Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trialBMC Cancer, 2015
- Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-AnalysisJournal of Clinical Oncology, 2012
- Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in JapanBritish Journal of Cancer, 2010
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 StudyBritish Journal of Cancer, 2009
- Gallbladder cancer (GBC): 10‐year experience at Memorial Sloan‐Kettering Cancer Centre (MSKCC)Journal of Surgical Oncology, 2008
- Carcinoma of the gallbladderThe Lancet Oncology, 2003
- Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?Cancer, 2002